2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$9.10+$0.35 (+4.02%)
Price as of Aug 03, 2026 10:19 AM EDT- $697.9MMarket Cap
- 4.79%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$9.10+$0.35 (+4.02%)
PHAT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.75 | ||
Change | -$0.28 (-3.10%) | ||
Open | $9.10 | ||
High | $9.49 | ||
Low | $8.66 | ||
Previous Close | $9.03 | ||
Volume | 3,312,139 | ||
30-Day Average Volume | 1,465,223 | ||
1-Week Change | -23.51% | ||
1-Month Change | -19.35% | ||
1-Year Change | 4.79% | ||
3-Year Change | -42.47% | ||
5-Year Change | -72.74% | ||
Fundamentals | |||
Shares Outstanding | 79.8M | ||
Total Assets | $327.1M | ||
Market Cap | $697.9M | ||
Enterprise Value | $680.0M | ||
Period: QTR TTM FY | |||
Revenue | $74.3M | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $142.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -56 | ||
Enterprise Value/Revenue | 9 | ||
P/B | -2 | ||
P/E | -42 | ||
PEG | -1 | ||
Price/Free Cash Flow | -354 | ||
Price/Operating Cash Flow | -362 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue